lipotropic and tirzepatide Weight Loss Injections Lipo-C (MIC + B Vitamins)

Endocrinology 151 (4), 14731486

In this blog, we will explain the FDAs ban, its implications, and what it means for you

The clinical researcher in me is excited by the numbers

In short: GLP-1/GIP therapies improve body composition , helping you lose fat while maintaining and often improving your lean-mass ratio and muscle function

However, another study found no significant correlation between endogenous GLP-1 levels and anticipatory activation for food cues (Perakakis et al., 2021)

Roche with its 2024 acquisition of Carmot, and Pfizer, following its 2025 acquisition of Metsera, enter obesity and broaden their presence in cardiovascular/metabolic, while other large pharmaceutical companies prepare to follow later in the decade